Healthcare

By

David Katz

 | Dec 2, 2014 | 8:30 AM EST

We are not ready to pull the buy trigger yet.

By

Bret Jensen

 | Nov 28, 2014 | 10:00 AM EST

The market seems to be severely discounting DynaVax's chances of approval for its hep-B treatment.

By

David Katz

 | Nov 25, 2014 | 2:30 PM EST

Whether it's acquiring or the acquired, Mylan is building shareholder value.

By

Gary Berman

 | Nov 24, 2014 | 9:23 AM EST

Is the company's stock about to start losing weight?

By

David Katz

 | Nov 21, 2014 | 9:30 AM EST

Its prospects exploded with a breakthrough drug.

By

Bret Jensen

 | Nov 20, 2014 | 8:30 AM EST

For speculative investors.

By

Jim Cramer

 | Nov 17, 2014 | 11:35 AM EST

The CEO of Allergan has created value for shareholders.

By

Bret Jensen

 | Nov 14, 2014 | 10:00 AM EST

Two speculative plays are worthy of consideration.

By

Gary Berman

 | Nov 4, 2014 | 11:35 AM EST

This beloved stock has triggered a long-term overbought signal again.

By

Bret Jensen

 | Oct 31, 2014 | 11:30 AM EDT

Drugs for liver diseases are good opportunities.

Shares of Lockheed Martin are pushing further into new all time high ground. LMT is...
We are feeling the pain today with our long GILD calls, these things happen and is why we ...
Mostly good start to trading week unless you are in energy stocks, which is now being impa...
As of 9;38 AM Knowles Corp. (KN) was up $1.14 per share (+ 5.65%) on very high volume of m...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.